Primary Record
Vapreotide
- In stock
- 5,230 g
- Purity
- 98.1 %
- CAS
- 103222-11-3
Compound Identifiers & Properties
- CAS
- 103222-11-3
- PubChem CID
- 71306
- SMILES
- CC(C)C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CC6=CNC7=CC=CC=C76)C(=O)N
- Canonical SMILES
- CC(C)C1NC(=O)C(CCCCN)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(NC(=O)C(N)Cc2ccccc2)CSSCC(C(=O)NC(Cc2c[nH]c3ccccc23)C(N)=O)NC1=O
Names & Synonyms
- Vapreotide
- Vapreotide acetate
- Vapreotida
- Vapreotidum
- Sanvar
- Sanvar IR
- Docrised (TN)
- Vapreotide [USAN:INN]
- Vapreotidum [INN-Latin]
- CCRIS 6495
- Vapreotida [INN-Spanish]
- AC1L2FXK
- 103222-11-3
- Vapreotide (USAN/INN)
- RC-160 (Vapreotide)
- D07DSQ
- UNII-2PK59M9GFF
- RC 160
- C57H70N12O9S2
- Vapreotide [USAN:INN:BAN]
- BMY 41606
- GTPL2054
- SCHEMBL6369050
- SCHEMBL30163296
- BDBM82464
- BCP21232
- CID71306
- AR-1B9977
- CAS_71306
- MFCD30489723
- NSC_71306
- RC-160
- RC160;BMY 41606
- AKOS015896024
- AN-7497
- FV73145
- C57-H70-N12-O9-S2
- LS-171852
- FT-0652516
- D06281
- F85455
- L001100
- I06-1827
- Sanvar IR; Vapreotidum; RC 160; RC-160; RC160
- ,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
- 10-(4-aminobutyl)-N-[1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-19-[(2-amino-3-phenylpropanoyl)amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
- 10-(4-aminobutyl)-N-[2-amino-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]-19-[(2-amino-3-phenyl-propanoyl)amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
- D-Phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-tryptophanamide cyclic (2->7)-disulfide
- (4R,7S,10S,13R,16S,19R)-13-((1H-Indol-3-yl)methyl)-N-((S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl)-19-((R)-2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
- (4R,7S,10S,13S,16S,19R)-10-(4-aminobutyl)-N-[(2R)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
- 10-(4-aminobutyl)-n-[1-amino-3-(1h-indol-3-yl)-1-oxopropan-2-yl]-16-(4-hydroxybenzyl)-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-7-(propan-2-yl)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
- 103667-11-4
- 116430-60-5
- 13-((1H-indol-3-yl)methyl)-N-(1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl)-19-(2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1
- D-Phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-tryptophanamide cyclic (2-7)-disulfide
- L-Tryptophanamide, D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2->7)-disulfide
- L-Tryptophanamide, D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide
- L-Tryptophanamide, D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2?7)-disulfide, acetate (1:?);L-Tryptophanamide, D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2?7)-disulfide, acetate (1:?)